Cytocare 532 / 640 / 715 (Non-cross-linked hyaluronic acid) by Revitacare.
Indications: Cytocare 532 — first signs of ageing and dull skin; 640 — dehydrated skin with visible wrinkles; 715 — mature skin with loss of firmness.
Administration: Mesotherapy / intradermal micro-injection; typically 3–4 sessions 2–3 weeks apart.
Storage: Store at room temperature.
Medical device (CE-marked). For use by qualified, licensed medical practitioners only.
| Manufacturer | Revitacare (France) |
| Active ingredient | Non-cross-linked hyaluronic acid (32 mg / 40 mg / 15 mg per 5 ml respectively) with a CT50 complex of vitamins, amino acids, minerals and nucleic acids. |
| Strength & pack | 10 × 5 ml vials (Cytocare 532 / 640) or pre-filled syringes (715). |
| Form | Injectable skin revitaliser |
| Storage | Store at room temperature. |
| Regulatory status | Medical device (CE-marked). For use by qualified, licensed medical practitioners only. |